GLUE

Monte Rosa Therapeutics, Inc. $10.76 as of 2026-10-30
Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+0.9%
Next 1 week
+2.2%
Next 1 month
+2.3%
Seasonality
Not enough history
20-year seasonality chart →
Mean reversion
Neutral — RSI(2) at 37
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is +0.33%/day.
Mean-reversion stats →
1-month breakdown — Market · β 0.91 +2.3% · Seasonal tilt (4y) +0.0%
$16M/day volume 81% volatility -14% 1-year -76% from ATH
52-week range · 7% of the way up · -58% from the high
$9.68$25.77

Earnings Full history →

Next report 2026-11-05 (Thursday, before open, in 5 days) · EPS est. -0.20.

1-day std dev
7.4%
Finished up
57%
Biggest pop
+16.3%
Biggest drop
-16.0%

Standard deviation of the close-to-close move over the last 21 reports. History, not a forecast.

ReportedEst.Actual SurpriseGap Day 1Day 5
2026-08-06 miss -0.37 -0.43 -17.6% +0.1% +0.6% +1.5%
2026-05-07 miss -0.38 -0.45 -19.1% -0.7% -2.8% -8.4%
2026-03-17 miss -0.34 -0.55 -63.4% -1.3% -2.0% -10.0%
2025-11-06 beat -0.35 -0.33 +6.4% +0.7% +5.7% +16.3%
2025-08-07 beat -0.38 -0.15 +60.2% +0.3% -2.9% -0.1%
2025-05-08 beat -0.32 0.57 +277.0% +18.7% +9.6% +0.5%
2025-03-20 beat 0.03 0.27 +902.6% -3.6% +5.4% -21.5%
2024-11-07 beat -0.47 -0.29 +38.4% +0.5% +0.8% -10.3%
2024-08-08 beat -0.54 -0.43 +20.5% +6.4% +10.2% +35.7%
2024-05-09 beat -0.58 -0.53 +8.2% -0.4% -1.5% -0.8%
2024-03-14 miss -0.39 -0.58 -49.8% -1.5% -8.4% +14.1%
2023-11-09 beat -0.74 -0.70 +5.7% -0.5% -10.6% -12.2%
2023-08-10 miss -0.69 -0.71 -2.7% +1.2% -1.6% -6.0%
2023-05-11 beat -0.68 -0.65 +5.1% +3.5% +1.0% -4.3%
2023-03-16 miss -0.62 -0.63 -1.3% -2.5% +7.4% +6.6%
2022-11-10 beat -0.59 -0.58 +2.2% +3.6% +5.3% +22.0%
2022-08-11 miss -0.47 -0.57 -20.4% +8.4% +5.2% +4.6%
2022-05-11 beat -0.54 -0.51 +5.9% +1.6% -16.0% -13.3%
2022-03-29 beat -0.51 -0.11 +78.2% +1.0% +16.3% +29.3%
2021-11-10 beat -0.44 -0.43 +2.1% -0.5% +4.1% +0.1%
2021-08-12 miss -0.38 -3.63 -842.9% -2.0% -3.9% -0.8%

Not investment advice.